Privacy AI
Regulatory

Health data compliance, handled.

Tell us what you need. We'll tell you what it takes and how long, before you commit.

Contact us

Summary

Contact us
On November 1st, the United Kingdom (UK) published the Bletchley Declaration on the opening day of the Artificial Intelligence (AI) Safety Summit hosted at Bletchley Park, central England.This declaration, made by the UK and joined by 28 countries and international organizations, aims to promote cooperation among them regarding AI.

‍

Why Bletchley ? It was at Bletchley Park that the Enigma code was successfully deciphered during WW2 …

International efforts are being made to examine and address the potential impact of AI systems, especially on principles such as the protection of human rights, data protection, and ethics.👉🏻 The primary focus of this declaration is on Frontier AI. These AI are defined as highly capable general-purpose AI models and specific narrow AI that could exhibit capabilities causing harm

The core concerns of the organizations revolve around the risks posed by Frontier AI, particularly in the domains of cybersecurity and biotechnology. Through international cooperation, they aim to deepen their understanding of these risks and identify actions to address them.

A regulatory approach will be considered by the participating organizations. This includes making, where appropriate, classifications and categorizations of risk based on national circumstances and applicable legal frameworks. International codes of conduct may result from this cooperation.

All AI actors are affected by this Declaration. Actors who develop Frontier AI have a significant responsibility to ensure the safety of these systems. The organizations encourage these actors to provide context-appropriate transparency and accountability in their plans to measure, monitor, and mitigate potentially harmful capabilities and associated effects, particularly to prevent misuse and issues of control, as well as the amplification of other risks.

‍

Click here to read more

Contact us

FAQs

Our frequently questions

No items found.

Seamus Larroque

CDPO / CPIM / ISO 27005 Certified

Find out how iliomad can help your company.

[Map placeholder]
Only visible in production
38.709099
-39.182035
1.6
6d17042a3425c5b3
Your message has been received!
We'll get back to you as soon as possible.
Something went wrong, please try again.
Home

Discover our latest articles

View All Blog Posts
Researcher reviewing AI-generated diagnostic imaging data on a screen in a clinical trial setting, with GDPR compliance documents visible on a desk
October 12, 2026
Regulations & Guidelines
GDPR
LLMS
US Privacy Law
Health Data Strategy

Medical trials and AI: navigating the GDPR, EHDS and EU AI Act overlap

Legal uncertainty surrounds AI use in medical trials. Learn how GDPR, the EHDS and the EU AI Act interact and what sponsors must do to stay compliant.

Diagram showing the CHAIN federated network connecting hospitals, health data hubs and cardiovascular disease registries across 20 European countries under the EHDS and EU AI Act framework
October 9, 2026
Healthtech
Regulations & Guidelines
GDPR
Big Data
Health Data Strategy

AI passports and EHDS: what the CHAIN network means for health AI governance

The EU CHAIN network introduces AI Passports and federated health data models. Learn what this means for GDPR compliance, high-risk AI obligations and clinical sites.

Abstract digital illustration of a secure health data network with EU and US regulatory symbols overlaid on a genomic strand background
October 8, 2026
Data Breach & Cybersecurity
Big Data
GDPR
Cybersecurity
Clinical Trials

Healthcare Data Breaches, AI Transparency and Clinical Research Standards: Weekly Digest

This week: Danish CPR breach, IQVIA Garante fine, OpenAI EU watermarking, Epic MyChart flaws, NIH funding decline and cancer trial QoL standards.